Narihito Seki
4PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jul 03, 2024
Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single-center prospective randomized controlled trial (VAPOR TRIAL).Narihito Seki, Hiroyuki Masaoka, Yoohyun Song
|Jun 20, 2022
A prospective, single-center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180-W GreenLight XPS laser, a 300-W diode laser, and a 200-W thulium laser for the treatment of benign prostatic hyperplasia.Tatsunori Okada, Mikifumi Koura, Ryota Sumikawa
|Jun 10, 2020
GreenLight HPS laser 120 W vs diode laser 300 W vaporization of the prostate for the treatment of benign prostatic hyperplasia in Japanese patients: A prospective, single-center, randomized clinical trial.Takeshi Kobayashi, Narihito Seki, Yoo H Song
|Oct 26, 2018
A 52-week multicenter randomized controlled study of the efficacy and safety of add-on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study).Tomonori Yamanishi, Hirotaka Asakura, Narihito Seki
Pageof 1
